Impact of pre‐lung transplant statin use on the development of primary graft dysfunction
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy2023Vol. 43(3), pp. 189–195
Citations Over Time
Abstract
Pre-transplant statin therapy did not appear to impact the development of PGD following lung transplantation. Future prospective studies should further evaluate the impact of statin intensity and duration on the incidence and severity of PGD.
Related Papers
- → Statin Prescribing Patterns in a Cohort of Cancer Patients with Poor Prognosis(2013)37 cited
- → Temporal Trend of Urolithiasis Incidence in China: An Age–Period–Cohort Analysis(2021)25 cited
- → Assessment of BED HIV-1 Incidence Assay in Seroconverter Cohorts: Effect of Individuals with Long-Term Infection and Importance of Stable Incidence(2011)13 cited
- → Reply to comment on “Risk factors for intensive care unit readmission after lung transplantation: a retrospective cohort study”(2023)1 cited
- → Arterial hypertension incidence rates in a cohort of nuclear workers(2016)1 cited